Conference abstractPublished 2017

Computerized behavioral assessments of novel model of multiple sclerosis

Authors: Denis Gris

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Multiple sclerosis is an autoimmune disease of the central nervous system. Recently, we have discovered an endogenous pathway that limits inflammation multiple sclerosis-like disease in mice. One of the key molecules of these pathways is Nlrx1 that belongs to Nlr family of proteins. Nlrs bind multiple proteins inside cells thus redirecting molecular signaling. Using state-of-the-art automated behavioral platform, we demonstrate that Nlrx1 inhibit progression of the diseases in a mouse model of MS. Furthermore, we were able to construct mice with increased predisposition to MS. These mice demonstrate the spontaneous appearance of the disease without any immunization. This model helped us to dissociate sickness behavioral profile from the behavioral signature of neuroinflammation. In addition, our results suggest that predisposition may rise from the disturbed homeostasis in the central nervous system rather than the peripheral activation of immune system. We observed that the inflammatory effect of Nlrx1 at the mitochondrial level, in inflammatory cells such as microglia and astrocytes, results in inhibition of assembly of proinflammatory pathways including Type I interferon and NFkB. Accordingly, we observed the reduction in the expression of iNOS, cytokines including IL-1beta and TNF-alpha during microglial activation. In neurons, Nlrx1 effect results in inhibition of necrosis and increased viability. Using N2A cell line, we demonstrated that Nlrx1 protects cells from rotenone toxicity. We demonstrated that Nlrx1 overexpressing cells were more viable than Nlrx1 KO cells and the ratio of apoptosis to necrosis was shifted to necrosis in cells that lacked Nlrx1. In conclusion, our study demonstrates that targeting central nervous system innate immune responses presents promising novel strategy treatments of multiple sclerosis.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in Journal of Neurology and Neuroscience.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Neurology and Neuroscience
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Denis Gris”